Literature DB >> 25485838

Mutations in the deubiquitinase gene USP8 cause Cushing's disease.

Martin Reincke1, Silviu Sbiera2, Akira Hayakawa3, Marily Theodoropoulou4, Andrea Osswald1, Felix Beuschlein1, Thomas Meitinger5, Emi Mizuno-Yamasaki3, Kohei Kawaguchi3, Yasushi Saeki6, Keiji Tanaka6, Thomas Wieland7, Elisabeth Graf7, Wolfgang Saeger8, Cristina L Ronchi9, Bruno Allolio10, Michael Buchfelder11, Tim M Strom12, Martin Fassnacht13, Masayuki Komada3.   

Abstract

Cushing's disease is caused by corticotroph adenomas of the pituitary. To explore the molecular mechanisms of endocrine autonomy in these tumors, we performed exome sequencing of 10 corticotroph adenomas. We found somatic mutations in the USP8 deubiquitinase gene in 4 of 10 adenomas. The mutations clustered in the 14-3-3 protein binding motif and enhanced the proteolytic cleavage and catalytic activity of USP8. Cleavage of USP8 led to increased deubiqutination of the EGF receptor, impairing its downregulation and sustaining EGF signaling. USP8 mutants enhanced promoter activity of the gene encoding proopiomelanocortin. In summary, our data show that dominant mutations in USP8 cause Cushing's disease via activation of EGF receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25485838     DOI: 10.1038/ng.3166

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  156 in total

Review 1.  Endocrinology research-reflecting on the past decade and looking to the next.

Authors:  Kevan C Herold; Joseph A Majzoub; Shlomo Melmed; Merri Pendergrass; Martin Schlumberger
Journal:  Nat Rev Endocrinol       Date:  2015-10-13       Impact factor: 43.330

2.  Stratifin regulates stabilization of receptor tyrosine kinases via interaction with ubiquitin-specific protease 8 in lung adenocarcinoma.

Authors:  Yunjung Kim; Aya Shiba-Ishii; Tomoki Nakagawa; Shun-Ichiro Iemura; Tohru Natsume; Noriyuki Nakano; Ryota Matsuoka; Shingo Sakashita; SangJoon Lee; Atsushi Kawaguchi; Yukio Sato; Masayuki Noguchi
Journal:  Oncogene       Date:  2018-06-07       Impact factor: 9.867

3.  The ubiquitin-specific protease USP8 deubiquitinates and stabilizes Cx43.

Authors:  Jian Sun; Qianwen Hu; Hong Peng; Cheng Peng; Liheng Zhou; Jinsong Lu; Chuanxin Huang
Journal:  J Biol Chem       Date:  2018-04-06       Impact factor: 5.157

Review 4.  Neonatal Cushing Syndrome: A Rare but Potentially Devastating Disease.

Authors:  Christina Tatsi; Constantine A Stratakis
Journal:  Clin Perinatol       Date:  2017-12-12       Impact factor: 3.430

Review 5.  Pituitary Medicine From Discovery to Patient-Focused Outcomes.

Authors:  Shlomo Melmed
Journal:  J Clin Endocrinol Metab       Date:  2016-02-23       Impact factor: 5.958

Review 6.  Is there a role for early chemotherapy in the management of pituitary adenomas?

Authors:  Andrew L Lin; Melissa W Sum; Lisa M DeAngelis
Journal:  Neuro Oncol       Date:  2016-04-21       Impact factor: 12.300

7.  Cushing's disease: towards precision medicine.

Authors:  Ursula B Kaiser
Journal:  Cell Res       Date:  2015-05-01       Impact factor: 25.617

8.  The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease.

Authors:  Luis G Perez-Rivas; Marily Theodoropoulou; Francesco Ferraù; Clara Nusser; Kohei Kawaguchi; Constantine A Stratakis; Fabio Rueda Faucz; Luiz E Wildemberg; Guillaume Assié; Rudi Beschorner; Christina Dimopoulou; Michael Buchfelder; Vera Popovic; Christina M Berr; Miklós Tóth; Arif Ibrahim Ardisasmita; Jürgen Honegger; Jerôme Bertherat; Monica R Gadelha; Felix Beuschlein; Günter Stalla; Masayuki Komada; Márta Korbonits; Martin Reincke
Journal:  J Clin Endocrinol Metab       Date:  2015-05-05       Impact factor: 5.958

Review 9.  Genomic Alterations in Sporadic Pituitary Tumors.

Authors:  Wenya Linda Bi; Alexandra Giantini Larsen; Ian F Dunn
Journal:  Curr Neurol Neurosci Rep       Date:  2018-02-02       Impact factor: 5.081

Review 10.  Genetics of Cushing's Syndrome.

Authors:  Laura C Hernández-Ramírez; Constantine A Stratakis
Journal:  Endocrinol Metab Clin North Am       Date:  2018-06       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.